Incidence, predictors and clinical management of hyperkalaemia in new users of mineralocorticoid receptor antagonists

BACKGROUND: Concerns for hyperkalaemia limit the use of mineralocorticoid receptor antagonists (MRAs). The frequency of MRA‐associated hyperkalaemia in real‐world settings and the extent of subsequent MRA discontinuation are poorly quantified. METHODS AND RESULTS: Observational study including all S...

Descripción completa

Detalles Bibliográficos
Autores principales: Trevisan, Marco, de Deco, Pietro, Xu, Hairong, Evans, Marie, Lindholm, Bengt, Bellocco, Rino, Barany, Peter, Jernberg, Tomas, Lund, Lars H., Carrero, Juan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607478/
https://www.ncbi.nlm.nih.gov/pubmed/29667759
http://dx.doi.org/10.1002/ejhf.1199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607478/
https://www.ncbi.nlm.nih.gov/pubmed/29667759
http://dx.doi.org/10.1002/ejhf.1199

Ejemplares similares